ai-based WuXi PharmaTech is the leading
China-based pharmaceutical and biotechnology R&D outsourcing company. As a
research- driven and customer-focused company, WuXi PharmaTech provides
pharmaceutical and biotechnology companies a broad and integrated portfolio
of laboratory and research manufacturing services throughout the drug
discovery and development process. WuXi PharmaTech's services are designed
to assist its global partners in shortening the cycle and lowering the cost
of drug discovery and development by providing cost-effective and efficient
outsourcing solutions that save its customers both time and money. Its
operations are grouped into two segments: laboratory services, consisting
of discovery chemistry, service biology, analytical, pharmaceutical
development and process development services, and manufacturing, focusing
on manufacturing of advanced intermediates and active pharmaceutical
ingredients for R&D use. In 2006, WuXi PharmaTech provided services to 70
pharmaceutical and biotechnology customers, including nine of the top ten
pharmaceutical companies in the world, as measured by 2006 total revenues.
For more information, please visit:
http://www.wuxipharmatech.com .
For more information, please contact:
Investor Contact:
Dr. Hai Mi
Vice President, Corporate Communications
WuXi PharmaTech Co., Ltd
Tel: +86-21-5046-3726
Email: ir@pharmatechs.com
Investor Relations (US):
Mahmoud Siddig
Director
Taylor Rafferty
Tel: +1-212-889-4350
Email: Pharmatechs@taylor-rafferty.com
Investor Relations (HK):
Ruby Yim
Managing Director
Taylor Rafferty
Tel: +852-3196-3712
Email: Pharmatechs@taylor-rafferty.com
Media Contact:
John Dooley
Taylor Rafferty
Tel: +1-212-889-4350
Email: Pharmatechs@tayl
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A2.
In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate3.
CIOs looking to hire more IT workers in second quarter4.
DNASTAR catches second wave of sequencing5.
9 tips for making 90 seconds count in an investment pitch6.
City of Hope adds second TomoTherapy system7.
UW-Madison hybrid-vehicle team places second nationally8.
Just one nanosecond: Clocking events at the nanoscale9.
MATCs new computer security program gears up for second semester10.
Weather Central launches second satellite11.
nPoint Secures Second Round of Funding